PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Persistent Fetal Circulation Syndrome D010547 1 associated lipids
Zollinger-Ellison Syndrome D015043 1 associated lipids
Anal Gland Neoplasms D000694 1 associated lipids
Mastocytosis, Systemic D034721 1 associated lipids
Trigeminal Neuralgia D014277 1 associated lipids
Pulmonary Aspergillosis D055732 1 associated lipids
Cryptorchidism D003456 2 associated lipids
Cystitis, Interstitial D018856 2 associated lipids
Decapitation D049248 2 associated lipids
Asthma, Aspirin-Induced D055963 2 associated lipids
Optic Neuropathy, Ischemic D018917 2 associated lipids
Choroid Diseases D015862 2 associated lipids
Angioedemas, Hereditary D054179 2 associated lipids
Epilepsy, Tonic-Clonic D004830 2 associated lipids
HTLV-I Infections D015490 3 associated lipids
Respiratory Sounds D012135 3 associated lipids
Ascariasis D001196 3 associated lipids
Sleep Disorders, Circadian Rhythm D020178 3 associated lipids
Wounds, Stab D014951 3 associated lipids
Graves Ophthalmopathy D049970 3 associated lipids
Cryptococcosis D003453 3 associated lipids
Cholangitis D002761 3 associated lipids
Leukemia, B-Cell D015448 3 associated lipids
Dirofilariasis D004184 3 associated lipids
Airway Remodeling D056151 3 associated lipids
Nasal Obstruction D015508 4 associated lipids
Idiopathic Pulmonary Fibrosis D054990 4 associated lipids
Goiter D006042 4 associated lipids
Headache D006261 4 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Meningoencephalitis D008590 4 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Coronavirus Infections D018352 4 associated lipids
Muscular Dystrophy, Animal D009137 5 associated lipids
Vasculitis, Leukocytoclastic, Cutaneous D018366 5 associated lipids
Hematoma D006406 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Leukodystrophy, Globoid Cell D007965 6 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Sneezing D012912 6 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Tauopathies D024801 6 associated lipids
Rhinitis, Allergic, Perennial D012221 6 associated lipids
Thrombophilia D019851 6 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Sleep Wake Disorders D012893 7 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Cholangiocarcinoma D018281 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Leukemia, Megakaryoblastic, Acute D007947 7 associated lipids
Folliculitis D005499 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Carotid Artery Thrombosis D002341 7 associated lipids
Thyroid Diseases D013959 8 associated lipids
Leiomyoma D007889 8 associated lipids
Retinopathy of Prematurity D012178 9 associated lipids
Leukemia, Basophilic, Acute D015471 9 associated lipids
Chondrosarcoma D002813 9 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Coronary Restenosis D023903 10 associated lipids
Rhinitis D012220 10 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Lymphoma, T-Cell D016399 11 associated lipids
Liver Failure, Acute D017114 11 associated lipids
Dehydration D003681 11 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Fetal Weight D020567 12 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Sarcoidosis D012507 13 associated lipids
Hypercalcemia D006934 13 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Urticaria D014581 13 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Dyskinesia, Drug-Induced D004409 15 associated lipids
HIV Seropositivity D006679 15 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Encephalitis D004660 15 associated lipids
Hyperlipoproteinemias D006951 15 associated lipids
Astrocytoma D001254 15 associated lipids
Blister D001768 16 associated lipids
Adenomatous Polyposis Coli D011125 16 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Down Syndrome D004314 18 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Bronchial Spasm D001986 18 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Peptic Ulcer D010437 19 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Cough D003371 19 associated lipids
Hypothermia D007035 19 associated lipids
Translocation, Genetic D014178 20 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Nelson SM et al. Selenoprotein Expression in Macrophages Is Critical for Optimal Clearance of Parasitic Helminth Nippostrongylus brasiliensis. 2016 J. Biol. Chem. pmid:26644468
Urade Y et al. Purification and characterization of rat brain prostaglandin D synthetase. 1985 J. Biol. Chem. pmid:3930495
Fournier T et al. Tumor necrosis factor-alpha inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. Synergistic action of cyclic AMP on cyclooxygenase-2 expression and prostaglandin E2 synthesis. 1997 J. Biol. Chem. pmid:9388257
Takeda K et al. 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. 2001 J. Biol. Chem. pmid:11687581
Bingham CO et al. A heparin-sensitive phospholipase A2 and prostaglandin endoperoxide synthase-2 are functionally linked in the delayed phase of prostaglandin D2 generation in mouse bone marrow-derived mast cells. 1996 J. Biol. Chem. pmid:8824228
Masamune A et al. Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells. 2002 J. Biol. Chem. pmid:11606585
Inoue H et al. Feedback control of cyclooxygenase-2 expression through PPARgamma. 2000 J. Biol. Chem. pmid:10827178
Ogburn KD and Figueiredo-Pereira ME Cytoskeleton/endoplasmic reticulum collapse induced by prostaglandin J2 parallels centrosomal deposition of ubiquitinated protein aggregates. 2006 J. Biol. Chem. pmid:16774923
Relic B et al. Peroxisome proliferator-activated receptor-gamma1 is dephosphorylated and degraded during BAY 11-7085-induced synovial fibroblast apoptosis. 2006 J. Biol. Chem. pmid:16766531
Cheng S et al. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. 2004 J. Biol. Chem. pmid:15023995
Alvarez-Maqueda M et al. 15-deoxy-delta 12,14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes. 2004 J. Biol. Chem. pmid:15024026
Reddy ST and Herschman HR Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells. 1997 J. Biol. Chem. pmid:9013559
Kuehn HS et al. Prostaglandin E2 activates and utilizes mTORC2 as a central signaling locus for the regulation of mast cell chemotaxis and mediator release. 2011 J. Biol. Chem. pmid:20980255
Sakamoto H et al. Involvement of phospholipid hydroperoxide glutathione peroxidase in the modulation of prostaglandin D2 synthesis. 2000 J. Biol. Chem. pmid:11010961
Kozak KR et al. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. 2000 J. Biol. Chem. pmid:10931854
He P et al. Oxidative stress suppresses cysteinyl leukotriene generation by mouse bone marrow-derived mast cells. 2011 J. Biol. Chem. pmid:21233206
Choi YH et al. The extracellular signal-regulated kinase mitogen-activated protein kinase/ribosomal S6 protein kinase 1 cascade phosphorylates cAMP response element-binding protein to induce MUC5B gene expression via D-prostanoid receptor signaling. 2011 J. Biol. Chem. pmid:21832046
Nie M et al. Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists. 2005 J. Biol. Chem. pmid:15531761
Werman A et al. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin. 1997 J. Biol. Chem. pmid:9242701
Eling TE et al. Oxidation of glutathione to its thiyl free radical metabolite by prostaglandin H synthase. A potential endogenous substrate for the hydroperoxidase. 1986 J. Biol. Chem. pmid:3007487
Koizumi T et al. Identification of a cis-regulatory element for delta 12-prostaglandin J2-induced expression of the rat heme oxygenase gene. 1995 J. Biol. Chem. pmid:7665598
Wang YL et al. Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival. 2002 J. Biol. Chem. pmid:12082115
Wilhelm D et al. SOX9 regulates prostaglandin D synthase gene transcription in vivo to ensure testis development. 2007 J. Biol. Chem. pmid:17277314
Stubbs VE et al. Indomethacin causes prostaglandin D(2)-like and eotaxin-like selective responses in eosinophils and basophils. 2002 J. Biol. Chem. pmid:11980903
Watanabe K et al. Enzymatic formation of prostaglandin F2 alpha from prostaglandin H2 and D2. Purification and properties of prostaglandin F synthetase from bovine lung. 1985 J. Biol. Chem. pmid:3858278
Richman JG et al. Nicotinic acid receptor agonists differentially activate downstream effectors. 2007 J. Biol. Chem. pmid:17452318
Schröder R et al. The C-terminal tail of CRTH2 is a key molecular determinant that constrains Galphai and downstream signaling cascade activation. 2009 J. Biol. Chem. pmid:19010788
Zavoico GB et al. Regulation of intracellular pH in human platelets. Effects of thrombin, A23187, and ionomycin and evidence for activation of Na+/H+ exchange and its inhibition by amiloride analogs. 1986 J. Biol. Chem. pmid:3020026
Chen Y et al. Formation of reactive cyclopentenone compounds in vivo as products of the isoprostane pathway. 1999 J. Biol. Chem. pmid:10196163
Caivano M et al. 15-Deoxy-Delta12,14-prostaglandin J2 regulates endogenous Cot MAPK kinase kinase 1 activity induced by lipopolysaccharide. 2003 J. Biol. Chem. pmid:14557273
Murakami M et al. Interleukin-3 regulates development of the 5-lipoxygenase/leukotriene C4 synthase pathway in mouse mast cells. 1995 J. Biol. Chem. pmid:7559381
Song WL et al. Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans. 2008 J. Biol. Chem. pmid:17993463
Boie Y et al. Molecular cloning and characterization of the human prostanoid DP receptor. 1995 J. Biol. Chem. pmid:7642548
Gao L et al. Formation of prostaglandins E2 and D2 via the isoprostane pathway: a mechanism for the generation of bioactive prostaglandins independent of cyclooxygenase. 2003 J. Biol. Chem. pmid:12746435
Nelson CA and Seamon KB Binding of [3H]forskolin to human platelet membranes. Regulation by guanyl-5'-yl imidodiphosphate, NaF, and prostaglandins E1 and D2. 1986 J. Biol. Chem. pmid:3463564
Lim SY et al. 15-Deoxy-Delta12,14-prostaglandin J(2) protects against nitrosative PC12 cell death through up-regulation of intracellular glutathione synthesis. 2004 J. Biol. Chem. pmid:15319433
Shibata T et al. Thioredoxin as a molecular target of cyclopentenone prostaglandins. 2003 J. Biol. Chem. pmid:12709421
Yu X et al. Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta12,14-prostaglandin J2 is attenuated by alkenal/one oxidoreductase. 2006 J. Biol. Chem. pmid:16857669
Chen ZH et al. Induction of adaptive response and enhancement of PC12 cell tolerance by 7-hydroxycholesterol and 15-deoxy-delta(12,14)-prostaglandin J2 through up-regulation of cellular glutathione via different mechanisms. 2006 J. Biol. Chem. pmid:16565077
Feinstein MB et al. Reversal of thrombin-induced myosin phosphorylation and the assembly of cytoskeletal structures in platelets by the adenylate cyclase stimulants prostaglandin D2 and forskolin. 1983 J. Biol. Chem. pmid:6571835
Li L et al. RasGRP4 regulates the expression of prostaglandin D2 in human and rat mast cell lines. 2003 J. Biol. Chem. pmid:12493770
Hilliard M et al. The anti-inflammatory prostaglandin 15-deoxy-delta(12,14)-PGJ2 inhibits CRM1-dependent nuclear protein export. 2010 J. Biol. Chem. pmid:20457605
Paruchuri S et al. Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells. 2008 J. Biol. Chem. pmid:18411276
Ishimoto T et al. Importance of the phospholipase D-initiated sequential pathway for arachidonic acid release and prostaglandin D2 generation by rat peritoneal mast cells. 1996 J. Biochem. pmid:8902628
Kimura K et al. Modulation of platelet activating factor-induced glycogenolysis in the perfused rat liver after administration of endotoxin in vivo. 1998 J. Biochem. pmid:9504421
Matsumoto K et al. Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration. 1995 J. Biochem. pmid:7608139
Sakamoto H et al. Effect of intracellular glutathione on the production of prostaglandin D2 in RBL-2H3 cells oxidized by tert-butyl hydroperoxide. 1999 J. Biochem. pmid:9880802
Irikura D et al. Cloning, expression, crystallization, and preliminary X-ray analysis of recombinant mouse lipocalin-type prostaglandin D synthase, a somnogen-producing enzyme. 2003 J. Biochem. pmid:12761195
Spatz M et al. Vasoactive peptides and prostaglandin D2 in human cerebromicrovascular endothelium. 1994 J. Auton. Nerv. Syst. pmid:7836668
Hardy CC et al. Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. 1988 J. Appl. Physiol. pmid:3288608
Cummings JJ Pulmonary vasodilator drugs decrease lung liquid production in fetal sheep. 1995 J. Appl. Physiol. pmid:8567564
Hayaishi O Molecular genetic studies on sleep-wake regulation, with special emphasis on the prostaglandin D(2) system. 2002 J. Appl. Physiol. pmid:11796702
Phillips GD and Holgate ST Interaction of inhaled LTC4 with histamine and PGD2 on airway caliber in asthma. 1989 J. Appl. Physiol. pmid:2917934
Fredberg JJ et al. Tissue resistance and the contractile state of lung parenchyma. 1993 J. Appl. Physiol. pmid:8482682
Kleeberger SR et al. Central role of cyclooxygenase in the response of canine peripheral airways to antigen. 1986 J. Appl. Physiol. pmid:2430928
Emery DL et al. Prostaglandin D2 causes accumulation of eosinophils in the lumen of the dog trachea. 1989 J. Appl. Physiol. pmid:2793725
Serio R and Daniel EE Thromboxane effects on canine trachealis neuromuscular function. 1988 J. Appl. Physiol. pmid:2839451
Underwood DC et al. Blockade of thromboxane responses in the airway of the cat by SQ 29,548. 1987 J. Appl. Physiol. pmid:2440845
Beasley RC et al. Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. 1989 J. Appl. Physiol. pmid:2525122
Tilden SJ et al. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2. 1987 J. Appl. Physiol. pmid:2954941
Myers AC et al. Influence of antigen on membrane properties of guinea pig bronchial ganglion neurons. 1991 J. Appl. Physiol. pmid:1721906
Walmrath D et al. Intravascular anti-IgE challenge in perfused lungs: mediator release and vascular pressor response. 1991 J. Appl. Physiol. pmid:1723406
Rajakulasingam K et al. Interactive effect of inhaled bradykinin with histamine and PGD2 in bronchial asthma. 1993 J. Appl. Physiol. pmid:8307852
McMahon TJ et al. Influence of SQ 30741 on thromboxane receptor-mediated responses in the feline pulmonary vascular bed. 1991 J. Appl. Physiol. pmid:1837015
Tamaoki J et al. Cholinergic neuromodulation by prostaglandin D2 in canine airway smooth muscle. 1987 J. Appl. Physiol. pmid:2891674
Piprek RP Genetic mechanisms underlying male sex determination in mammals. 2009 J. Appl. Genet. pmid:19875885
Tsutsumi S et al. Cerebrospinal fluid drainage through the diploic and spinal epidural veins. 2015 J. Anat. pmid:26184099
Stamatakis K et al. Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton. 2006 J. Am. Soc. Nephrol. pmid:16291835
Ito H et al. PGD2-CRTH2 pathway promotes tubulointerstitial fibrosis. 2012 J. Am. Soc. Nephrol. pmid:22997255
Ruan XZ et al. PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. 2003 J. Am. Soc. Nephrol. pmid:12595494
Arici M et al. Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma. 2003 J. Am. Soc. Nephrol. pmid:12506134
Rovin BH et al. Cyclopentenone prostaglandins inhibit cytokine-induced nf-kappab activation and chemokine production by human mesangial cells. 2001 J. Am. Soc. Nephrol. pmid:11461938
Li Y et al. Prediction of the 3D structure and dynamics of human DP G-protein coupled receptor bound to an agonist and an antagonist. 2007 J. Am. Chem. Soc. pmid:17691773
Yamaguchi S et al. Delta12-prostaglandin J2 as a product and ligand of human serum albumin: formation of an unusual covalent adduct at His146. 2010 J. Am. Chem. Soc. pmid:20014793
VanderEnde DS and Morrow JD Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans after the application of cinnamic aldehyde. 2001 J. Am. Acad. Dermatol. pmid:11423836
Reddy PH Inhibitors of mitochondrial fission as a therapeutic strategy for diseases with oxidative stress and mitochondrial dysfunction. 2014 J. Alzheimers Dis. pmid:24413616
Ahluwalia P et al. Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms. 2001 J. Allergy Clin. Immunol. pmid:11544467
Feng X et al. Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease. 2016 J. Allergy Clin. Immunol. pmid:27423494
Pienkowski MM et al. Prostaglandin D2 and histamine during the immediate and the late-phase components of allergic cutaneous responses. 1988 J. Allergy Clin. Immunol. pmid:3292634
Atkins PC et al. In vivo antigen-induced cutaneous mediator release: simultaneous comparisons of histamine, tryptase, and prostaglandin D2 release and the effect of oral corticosteroid administration. 1990 J. Allergy Clin. Immunol. pmid:1698845
Akin C et al. Mast cell activation syndrome: Proposed diagnostic criteria. 2010 J. Allergy Clin. Immunol. pmid:21035176
Gervais FG et al. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. 2001 J. Allergy Clin. Immunol. pmid:11742277
Magnussen H et al. Effects of a thromboxane-receptor antagonist, BAY u 3405, on prostaglandin D2- and exercise-induced bronchoconstriction. 1992 J. Allergy Clin. Immunol. pmid:1535083
Heavey DJ et al. Prostaglandin D2 and histamine release in cold urticaria. 1986 J. Allergy Clin. Immunol. pmid:2428856
Emery BE et al. The effect of IL-4 on human nasal mucosal responses. 1992 J. Allergy Clin. Immunol. pmid:1430703
Fajt ML et al. Prostaglandin Dâ‚‚ pathway upregulation: relation to asthma severity, control, and TH2 inflammation. 2013 J. Allergy Clin. Immunol. pmid:23506843
Charlesworth EN et al. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. 1989 J. Allergy Clin. Immunol. pmid:2469708
Wachs M et al. Observations on the pathogenesis of nasal priming. 1989 J. Allergy Clin. Immunol. pmid:2477429
Huszár E et al. Elevated circulating adenosine level potentiates antigen-induced immediate bronchospasm and bronchoconstrictor mediator release in sensitized guinea pigs. 1998 J. Allergy Clin. Immunol. pmid:9802380
Shichijo M et al. Role of cyclic 3',5'-adenosine monophosphate in the regulation of chemical mediator release and cytokine production from cultured human mast cells. 1999 J. Allergy Clin. Immunol. pmid:10329844
Xue L et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. 2014 J. Allergy Clin. Immunol. pmid:24388011
Ormerod AD et al. Prostaglandin D2 and histamine release in cold urticaria unaccompanied by evidence of platelet activation. 1988 J. Allergy Clin. Immunol. pmid:2459177
Lebel B et al. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains. 1988 J. Allergy Clin. Immunol. pmid:2461405
Bousquet J et al. Antiallergic activity of H1-receptor antagonists assessed by nasal challenge. 1988 J. Allergy Clin. Immunol. pmid:2461406
Norman PS The John Sheldon memorial lecture. Review of nasal therapy: update. 1983 J. Allergy Clin. Immunol. pmid:6195204
Bochenek G et al. A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. 2003 J. Allergy Clin. Immunol. pmid:12704352
Szczeklik W et al. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. 2004 J. Allergy Clin. Immunol. pmid:15316498
Schleimer RP et al. Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. 1984 J. Allergy Clin. Immunol. pmid:6208229
Arzubiaga C et al. Neuropeptide Y, a putative cotransmitter in noradrenergic neurons, induces mast cell degranulation but not prostaglandin D2 release. 1991 J. Allergy Clin. Immunol. pmid:1825102
Awad JA et al. Detection of the major urinary metabolite of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation. 1994 J. Allergy Clin. Immunol. pmid:8182221